Author:
Sambasivan Khrishanthne,Tyrrell Will E.,Farooq Rizwan,Mynerich Jenasee,Edwards Richard S.,Tanc Muhammet,Urbano Teresa Guerrero,Witney Timothy H.
Abstract
AbstractThe ability to image early treatment response to radiotherapy in head and neck squamous cell carcinoma (HNSCC) will enable the identification of radioresistant tumor volumes suitable for treatment intensification. Here, we propose the system xc− radiotracer (4S)-4-(3-[18F]fluoropropyl)-L-glutamate ([18F]FSPG) as a non-invasive method to monitor radiation response in HNSCC. We assessed temporal changes in cell death, antioxidant status, and [18F]FSPG retention following a single dose of 10 Gy irradiation in FaDU HNSCC cells. Next, using a fractionated course of radiotherapy, we assessed tumor volume changes and performed [18F]FSPG-PET imaging in FaDU-bearing mouse xenografts, followed by ex vivo response assessment. In cells, 10 Gy irradiation reduced [18F]FSPG retention, coinciding with the induction of apoptosis and the production of reactive oxygen species. In vivo, [18F]FSPG tumor retention was halved seven days after the start of treatment, which preceded radiotherapy-induced tumor shrinkage, thereby confirming [18F]FSPG-PET as an early and sensitive marker of radiation response.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Huang, J. et al. Early treatment response monitoring using 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography imaging during fractionated radiotherapy of head neck cancer xenografts. Biomed. Res. Int. 2014, 598052 (2014).
2. Strojan, P. et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat. Rev. 59, 79–92 (2017).
3. Pigorsch, S. U. et al. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol. Radiat. Oncol. 12, 45 (2017).
4. Overgaard, J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis. Radiother. Oncol. 100, 22–32 (2011).
5. Wee, J. T. et al. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 10, 1086–1092 (2009).